Global HER2 Target Drugs Supply, Demand and Key Producers, 2023-2029

Global HER2 Target Drugs Supply, Demand and Key Producers, 2023-2029

The global HER2 Target Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.

This report studies the global HER2 Target Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for HER2 Target Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Target Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global HER2 Target Drugs total production and demand, 2018-2029, (K Units)

Global HER2 Target Drugs total production value, 2018-2029, (USD Million)

Global HER2 Target Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global HER2 Target Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: HER2 Target Drugs domestic production, consumption, key domestic manufacturers and share

Global HER2 Target Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global HER2 Target Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global HER2 Target Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global HER2 Target Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda and Daiichi Sankyo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Target Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global HER2 Target Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global HER2 Target Drugs Market, Segmentation by Type
Monoclonal Antibodies
Small Molecule Chemicals
Antibody Drug Conjugate

Global HER2 Target Drugs Market, Segmentation by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer
Other

Companies Profiled:
Roche
GSK
Boehringer Digelheim
Pfizer
AstraZeneca
Seagen
MacroGenics
Takeda
Daiichi Sankyo
Novartis AG
RemeGen
Sunshine Guojian
Hengrui Medicine

Key Questions Answered

1. How big is the global HER2 Target Drugs market?

2. What is the demand of the global HER2 Target Drugs market?

3. What is the year over year growth of the global HER2 Target Drugs market?

4. What is the production and production value of the global HER2 Target Drugs market?

5. Who are the key producers in the global HER2 Target Drugs market?